In this review, we discuss potential therapeutic strategies of targeting PSMA to deliver specific miRNA payloads exclusively to PC tumors as well as provide insight into various delivery systems for miRNAs and the challenges to using these systems for therapy. The gene discussed is FOLH1; the disease is pachyonychia congenita.